During the past decade, Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "B-cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" in a lesser frequency.

Most popular intervention types in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Rituximab" (2 trials), "Atezolizumab Placebo" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".